RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,786 | -32.7% | 19,713 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $246,314 | -18.9% | 19,611 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $303,592 | -3.0% | 18,433 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $312,993 | -20.6% | 20,950 | +19.1% | 0.00% | -50.0% |
| Q3 2022 | $394,000 | +37.8% | 17,595 | +3.2% | 0.00% | +100.0% |
| Q2 2022 | $286,000 | -60.7% | 17,057 | -29.9% | 0.00% | -50.0% |
| Q1 2022 | $728,000 | -22.2% | 24,327 | -20.2% | 0.00% | 0.0% |
| Q4 2021 | $936,000 | +8.0% | 30,500 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $867,000 | -25.5% | 27,495 | -13.5% | 0.00% | -33.3% |
| Q2 2021 | $1,163,000 | +36.2% | 31,786 | +28.7% | 0.00% | 0.0% |
| Q1 2021 | $854,000 | -2.2% | 24,706 | +17.6% | 0.00% | 0.0% |
| Q4 2020 | $873,000 | – | 21,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |